Rose Crombag

Rose Crombag is a Researcher in the Pharmacy department at Erasmus University Medical Center (Erasmus MC), Rotterdam, specializing in clinical pharmacology and pharmaceutical sciences with a focus on optimizing drug therapy through pharmacokinetic analysis and translational research.

Research Focus: Her work centers on pharmacokinetics across diverse populations, particularly investigating drug exposure in oncology (e.g., doxorubicin, gemcitabine) and inflammatory conditions (e.g., ustekinumab in Crohn's disease). She explores inflammation mechanisms, tissue/serum drug level correlations, and drug repurposing strategies like indomethacin for antiviral applications. Her fingerprint highlights strong expertise in paclitaxel, neutropenia, and inflammatory bowel disease therapeutics.

Publication Trends: Recent work demonstrates a shift toward sustainable healthcare practices (2025 cost-effectiveness study) alongside core pharmacokinetic modeling. Her 2022-2025 publications reveal consistent integration of clinical data with pharmacometric analysis to personalize dosing, enhance drug safety, and evaluate real-world therapeutic outcomes across age groups and disease states.